Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1990 2
1991 2
1994 1
1995 2
1996 3
1997 3
1998 2
1999 4
2000 6
2001 6
2002 2
2003 2
2004 2
2005 1
2006 2
2007 2
2008 1
2009 1
2010 1
2011 1
2014 1
2017 1
2018 1
2019 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Novel bone antiresorptive approaches.
Lark MW, James IE. Lark MW, et al. Among authors: james ie. Curr Opin Pharmacol. 2002 Jun;2(3):330-7. doi: 10.1016/s1471-4892(02)00166-2. Curr Opin Pharmacol. 2002. PMID: 12020479 Review.
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.
Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR. Emery JG, et al. Among authors: james ie. J Biol Chem. 1998 Jun 5;273(23):14363-7. doi: 10.1074/jbc.273.23.14363. J Biol Chem. 1998. PMID: 9603945 Free article.
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects.
Fossler MJ, Schmith V, Greene SA, Lohmer L, Kramer MS, Arscott K, James IE, Demitrack MA. Fossler MJ, et al. Among authors: james ie. CNS Drugs. 2020 Aug;34(8):853-865. doi: 10.1007/s40263-020-00738-0. CNS Drugs. 2020. PMID: 32676977 Free PMC article. Clinical Trial.
Azepanone-based inhibitors of human and rat cathepsin K.
Marquis RW, Ru Y, LoCastro SM, Zeng J, Yamashita DS, Oh HJ, Erhard KF, Davis LD, Tomaszek TA, Tew D, Salyers K, Proksch J, Ward K, Smith B, Levy M, Cummings MD, Haltiwanger RC, Trescher G, Wang B, Hemling ME, Quinn CJ, Cheng HY, Lin F, Smith WW, Janson CA, Zhao B, McQueney MS, D'Alessio K, Lee CP, Marzulli A, Dodds RA, Blake S, Hwang SM, James IE, Gress CJ, Bradley BR, Lark MW, Gowen M, Veber DF. Marquis RW, et al. Among authors: james ie. J Med Chem. 2001 Apr 26;44(9):1380-95. doi: 10.1021/jm000481x. J Med Chem. 2001. PMID: 11311061
Physician communication techniques and weight loss in adults: Project CHAT.
Pollak KI, Alexander SC, Coffman CJ, Tulsky JA, Lyna P, Dolor RJ, James IE, Brouwer RJ, Manusov JR, Østbye T. Pollak KI, et al. Among authors: james ie. Am J Prev Med. 2010 Oct;39(4):321-8. doi: 10.1016/j.amepre.2010.06.005. Am J Prev Med. 2010. PMID: 20837282 Free PMC article.
Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonists.
Miller WH, Manley PJ, Cousins RD, Erhard KF, Heerding DA, Kwon C, Ross ST, Samanen JM, Takata DT, Uzinskas IN, Yuan CC, Haltiwanger RC, Gress CJ, Lark MW, Hwang SM, James IE, Rieman DJ, Willette RN, Yue TL, Azzarano LM, Salyers KL, Smith BR, Ward KW, Johanson KO, Huffman WF. Miller WH, et al. Among authors: james ie. Bioorg Med Chem Lett. 2003 Apr 17;13(8):1483-6. doi: 10.1016/s0960-894x(03)00102-1. Bioorg Med Chem Lett. 2003. PMID: 12668017
51 results